Lunai Bioworks receives Nasdaq notice for non-compliance with $35 million market value rule
NegativeFinancial Markets

Lunai Bioworks has received a notice from Nasdaq regarding its non-compliance with the $35 million market value rule. This situation is significant as it raises concerns about the company's financial health and its ability to meet regulatory standards, which could impact investor confidence and future operations.
— Curated by the World Pulse Now AI Editorial System










